Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Horowitz

Showing results (631-640 of 701) with videos related to

Pageof 71
Sort By:
Gynecologic Oncology|January 13, 2019
Infection, thrombosis, and oncologic outcome after interval debulking surgery: Does perioperative blood transfusion matter?Beryl L Manning-Geist, Stephanie Alimena, Marcela G Del Carmen, et al.
The Journal of Pathology|July 26, 2018
Evidence for lineage continuity between early serous proliferations (ESPs) in the Fallopian tube and disseminated high-grade serous carcinomasThing Rinda Soong, Brooke E Howitt, Alexander Miron, et al.
Gynecologic Oncology|February 11, 2015
Does plastic surgical consultation improve the outcome of patients undergoing radical vulvectomy for squamous cell carcinoma of the vulva?Emeline M Aviki, Katharine M Esselen, Sara M Barcia, et al.
Acta Neuropathologica Communications|December 14, 2023
ApoER2-Dab1 disruption as the origin of pTau-associated neurodegeneration in sporadic Alzheimer's diseaseChristopher E Ramsden, Daisy Zamora, Mark S Horowitz, et al.
Gynecologic Oncology|April 3, 2019
Diagnosis and management of a recurrent polymerase-epsilon (POLE)-mutated endometrial cancerJennifer Taylor Veneris, Elizabeth K Lee, Emily A Goebel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 13, 2008
Phase II study of carboplatin and pemetrexed for the treatment of platinum-sensitive recurrent ovarian cancerUrsula A Matulonis, Neil S Horowitz, Susana M Campos, et al.
Gynecologic Oncology|September 21, 2020
Neoadjuvant chemotherapy does not disproportionately influence post-operative complication rates or time to chemotherapy in obese patients with advanced-stage ovarian cancerAlexa N Kanbergs, Beryl L Manning-Geist, Andrea Pelletier, et al.
Radiation Protection Dosimetry|April 29, 2006
Search for ionisation density effects in the radiation absorption stage in LiF:Mg,TiI Nail, Y S Horowitz, L Oster, et al.
Revista Brasileira De Ginecologia E Obstetricia : Revista Da Federacao Brasileira Das Sociedades De Ginecologia E Obstetricia|June 27, 2022
Clinical Presentation, Treatment Outcomes, and Resistance-related Factors in South American Women with Low-risk Postmolar Gestational Trophoblastic NeoplasiaLuz Angela Correa Ramírez, Izildinha Maestá, María Inés Bianconi, et al.
American Journal of Obstetrics and Gynecology|April 8, 2014
What is the optimal treatment for obese patients with advanced ovarian carcinoma?Michael J Worley, Stephanie H Guseh, J Alejandro Rauh-Hain, et al.
Pageof 71

Showing results (631-640 of 701) with videos related to

Sort By:
Pageof 71
Gynecologic Oncology|January 13, 2019
Infection, thrombosis, and oncologic outcome after interval debulking surgery: Does perioperative blood transfusion matter?Beryl L Manning-Geist, Stephanie Alimena, Marcela G Del Carmen, et al.
The Journal of Pathology|July 26, 2018
Evidence for lineage continuity between early serous proliferations (ESPs) in the Fallopian tube and disseminated high-grade serous carcinomasThing Rinda Soong, Brooke E Howitt, Alexander Miron, et al.
Gynecologic Oncology|February 11, 2015
Does plastic surgical consultation improve the outcome of patients undergoing radical vulvectomy for squamous cell carcinoma of the vulva?Emeline M Aviki, Katharine M Esselen, Sara M Barcia, et al.
Acta Neuropathologica Communications|December 14, 2023
ApoER2-Dab1 disruption as the origin of pTau-associated neurodegeneration in sporadic Alzheimer's diseaseChristopher E Ramsden, Daisy Zamora, Mark S Horowitz, et al.
Gynecologic Oncology|April 3, 2019
Diagnosis and management of a recurrent polymerase-epsilon (POLE)-mutated endometrial cancerJennifer Taylor Veneris, Elizabeth K Lee, Emily A Goebel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 13, 2008
Phase II study of carboplatin and pemetrexed for the treatment of platinum-sensitive recurrent ovarian cancerUrsula A Matulonis, Neil S Horowitz, Susana M Campos, et al.
Gynecologic Oncology|September 21, 2020
Neoadjuvant chemotherapy does not disproportionately influence post-operative complication rates or time to chemotherapy in obese patients with advanced-stage ovarian cancerAlexa N Kanbergs, Beryl L Manning-Geist, Andrea Pelletier, et al.
Radiation Protection Dosimetry|April 29, 2006
Search for ionisation density effects in the radiation absorption stage in LiF:Mg,TiI Nail, Y S Horowitz, L Oster, et al.
Revista Brasileira De Ginecologia E Obstetricia : Revista Da Federacao Brasileira Das Sociedades De Ginecologia E Obstetricia|June 27, 2022
Clinical Presentation, Treatment Outcomes, and Resistance-related Factors in South American Women with Low-risk Postmolar Gestational Trophoblastic NeoplasiaLuz Angela Correa Ramírez, Izildinha Maestá, María Inés Bianconi, et al.
American Journal of Obstetrics and Gynecology|April 8, 2014
What is the optimal treatment for obese patients with advanced ovarian carcinoma?Michael J Worley, Stephanie H Guseh, J Alejandro Rauh-Hain, et al.
Pageof 71